Cancer Care Management During the COVID-19 Pandemic

• Published in: Risk management and healthcare policy Vol. 13; pp. 1711 - 1721
• Main Authors: Jafari, Ameneh, Rezaei-Tavirani, Mostafa, Karami, Samira, Yazdani, Mohsen, Zali, Hakimeh, Jafari, Zahra
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis Ltd 01.01.2020; Dove; Dove Medical Press
• Subjects: Cancer; coronavirus; Coronaviruses; COVID-19; Epidemiology; Fatalities; health care; Mortality; pandemic; Pandemics; Review; sars-cov-2; Viral infections; Viruses; Italy; United Kingdom > UK; United States > US; Germany; Spain; coronavirus; SARS-CoV-2; cancer; pandemic; health care
• ISSN: 1179-1594; 1179-1594
• DOI: 10.2147/RMHP.S261357

New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.